These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 32916545)

  • 1. Structure-based functional analysis of BRCA1 RING domain variants: Concordance of computational mutagenesis, experimental assay, and clinical data.
    Masso M; Bansal A; Bansal A; Henderson A
    Biophys Chem; 2020 Nov; 266():106442. PubMed ID: 32916545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional analysis of BRCA1 RING domain variants: computationally derived structural data can improve upon experimental features for training predictive models.
    Masso M
    Integr Biol (Camb); 2020 Sep; 12(9):233-239. PubMed ID: 32984879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of amino acid substitutions at secondary structures in the BRCT domains of the tumor suppressor BRCA1: Implications for clinical annotation.
    Fernandes VC; Golubeva VA; Di Pietro G; Shields C; Amankwah K; Nepomuceno TC; de Gregoriis G; Abreu RBV; Harro C; Gomes TT; Silva RF; Suarez-Kurtz G; Couch FJ; Iversen ES; Monteiro ANA; Carvalho MA
    J Biol Chem; 2019 Apr; 294(15):5980-5992. PubMed ID: 30765603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Massively Parallel Functional Analysis of BRCA1 RING Domain Variants.
    Starita LM; Young DL; Islam M; Kitzman JO; Gullingsrud J; Hause RJ; Fowler DM; Parvin JD; Shendure J; Fields S
    Genetics; 2015 Jun; 200(2):413-22. PubMed ID: 25823446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive analysis of missense variations in the BRCT domain of BRCA1 by structural and functional assays.
    Lee MS; Green R; Marsillac SM; Coquelle N; Williams RS; Yeung T; Foo D; Hau DD; Hui B; Monteiro AN; Glover JN
    Cancer Res; 2010 Jun; 70(12):4880-90. PubMed ID: 20516115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Multiplex Homology-Directed DNA Repair Assay Reveals the Impact of More Than 1,000 BRCA1 Missense Substitution Variants on Protein Function.
    Starita LM; Islam MM; Banerjee T; Adamovich AI; Gullingsrud J; Fields S; Shendure J; Parvin JD
    Am J Hum Genet; 2018 Oct; 103(4):498-508. PubMed ID: 30219179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A high-throughput functional complementation assay for classification of BRCA1 missense variants.
    Bouwman P; van der Gulden H; van der Heijden I; Drost R; Klijn CN; Prasetyanti P; Pieterse M; Wientjens E; Seibler J; Hogervorst FB; Jonkers J
    Cancer Discov; 2013 Oct; 3(10):1142-55. PubMed ID: 23867111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probing structure-function relationships in missense variants in the carboxy-terminal region of BRCA1.
    Carvalho RS; Abreu RB; Velkova A; Marsillac S; Rodarte RS; Suarez-Kurtz G; Iversen ES; Monteiro AN; Carvalho MA
    PLoS One; 2014; 9(5):e97766. PubMed ID: 24845084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of a set of missense, frameshift, and in-frame deletion variants of BRCA1.
    Carvalho M; Pino MA; Karchin R; Beddor J; Godinho-Netto M; Mesquita RD; Rodarte RS; Vaz DC; Monteiro VA; Manoukian S; Colombo M; Ripamonti CB; Rosenquist R; Suthers G; Borg A; Radice P; Grist SA; Monteiro AN; Billack B
    Mutat Res; 2009 Jan; 660(1-2):1-11. PubMed ID: 18992264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive evaluation and efficient classification of BRCA1 RING domain missense substitutions.
    Clark KA; Paquette A; Tao K; Bell R; Boyle JL; Rosenthal J; Snow AK; Stark AW; Thompson BA; Unger J; Gertz J; Varley KE; Boucher KM; Goldgar DE; Foulkes WD; Thomas A; Tavtigian SV
    Am J Hum Genet; 2022 Jun; 109(6):1153-1174. PubMed ID: 35659930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The functional impact of BRCA1 BRCT domain variants using multiplexed DNA double-strand break repair assays.
    Adamovich AI; Diabate M; Banerjee T; Nagy G; Smith N; Duncan K; Mendoza Mendoza E; Prida G; Freitas MA; Starita LM; Parvin JD
    Am J Hum Genet; 2022 Apr; 109(4):618-630. PubMed ID: 35196514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new bioinformatics tool to help assess the significance of BRCA1 variants.
    Cusin I; Teixeira D; Zahn-Zabal M; Rech de Laval V; Gleizes A; Viassolo V; Chappuis PO; Hutter P; Bairoch A; Gaudet P
    Hum Genomics; 2018 Jul; 12(1):36. PubMed ID: 29996917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of BRCA1 missense variants V1804D and M1628T on transcriptional activity.
    Ostrow KL; McGuire V; Whittemore AS; DiCioccio RA
    Cancer Genet Cytogenet; 2004 Sep; 153(2):177-80. PubMed ID: 15350310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A high proportion of DNA variants of BRCA1 and BRCA2 is associated with aberrant splicing in breast/ovarian cancer patients.
    Sanz DJ; Acedo A; Infante M; Durán M; Pérez-Cabornero L; Esteban-Cardeñosa E; Lastra E; Pagani F; Miner C; Velasco EA
    Clin Cancer Res; 2010 Mar; 16(6):1957-67. PubMed ID: 20215541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combining Homologous Recombination and Phosphopeptide-binding Data to Predict the Impact of
    Petitalot A; Dardillac E; Jacquet E; Nhiri N; Guirouilh-Barbat J; Julien P; Bouazzaoui I; Bonte D; Feunteun J; Schnell JA; Lafitte P; Aude JC; Noguès C; Rouleau E; Lidereau R; Lopez BS; Zinn-Justin S; Caputo SM;
    Mol Cancer Res; 2019 Jan; 17(1):54-69. PubMed ID: 30257991
    [No Abstract]   [Full Text] [Related]  

  • 16. Multiplexed assay of variant effect reveals residues of functional importance in the BRCA1 coiled-coil and serine cluster domains.
    Nagy G; Diabate M; Banerjee T; Adamovich AI; Smith N; Jeon H; Dhar S; Liu W; Burgess K; Chung D; Starita LM; Parvin JD
    PLoS One; 2023; 18(11):e0293422. PubMed ID: 37917606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional Analysis of BARD1 Missense Variants in Homology-Directed Repair of DNA Double Strand Breaks.
    Lee C; Banerjee T; Gillespie J; Ceravolo A; Parvinsmith MR; Starita LM; Fields S; Toland AE; Parvin JD
    Hum Mutat; 2015 Dec; 36(12):1205-14. PubMed ID: 26350354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic, functional, and histopathological evaluation of two C-terminal BRCA1 missense variants.
    Lovelock PK; Healey S; Au W; Sum EY; Tesoriero A; Wong EM; Hinson S; Brinkworth R; Bekessy A; Diez O; Izatt L; Solomon E; Jenkins M; Renard H; Hopper J; Waring P; Tavtigian SV; Goldgar D; Lindeman GJ; Visvader JE; Couch FJ; Henderson BR; Southey M; Chenevix-Trench G; Spurdle AB; Brown MA;
    J Med Genet; 2006 Jan; 43(1):74-83. PubMed ID: 15923272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional analysis of BRCA1 C-terminal missense mutations identified in breast and ovarian cancer families.
    Vallon-Christersson J; Cayanan C; Haraldsson K; Loman N; Bergthorsson JT; Brøndum-Nielsen K; Gerdes AM; Møller P; Kristoffersson U; Olsson H; Borg A; Monteiro AN
    Hum Mol Genet; 2001 Feb; 10(4):353-60. PubMed ID: 11157798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A structural bioinformatics approach to explore the interactions of P53 and BRCA1 gene products on ovarian and breast cancer.
    Parija S; Kumar A
    Int J Bioinform Res Appl; 2011; 7(1):1-14. PubMed ID: 21441093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.